Follow
Evdoxia Karali
Evdoxia Karali
Senior Research Scientist
Verified email at icr.ac.uk
Title
Cited by
Cited by
Year
VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress
E Karali, S Bellou, D Stellas, A Klinakis, C Murphy, T Fotsis
Molecular cell 54 (4), 559-572, 2014
1902014
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
AK Najumudeen, F Ceteci, SK Fey, G Hamm, RT Steven, H Hall, ...
Nature genetics 53 (1), 16-26, 2021
1252021
Metabolic fingerprinting links oncogenic PIK3CA with enhanced arachidonic acid-derived eicosanoids
N Koundouros, E Karali, A Tripp, A Valle, P Inglese, NJS Perry, DJ Magee, ...
Cell 181 (7), 1596-1611. e27, 2020
902020
Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity
A Primikyri, MV Chatziathanasiadou, E Karali, E Kostaras, MD Mantzaris, ...
ACS chemical biology 9 (12), 2737-2741, 2014
772014
Universal sample preparation unlocking multimodal molecular tissue imaging
A Dannhorn, E Kazanc, S Ling, C Nikula, E Karali, MP Serra, JL Vorng, ...
Analytical Chemistry 92 (16), 11080-11088, 2020
662020
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth
S Bellou, E Karali, E Bagli, N Al-Maharik, L Morbidelli, M Ziche, ...
Molecular cancer 11, 1-11, 2012
432012
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer
J Antony, E Zanini, Z Kelly, TZ Tan, E Karali, M Alomary, Y Jung, K Nixon, ...
EMBO reports 19 (8), e45670, 2018
382018
The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR-and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer
E Zanini, LS Louis, J Antony, E Karali, IS Okon, AB McKie, S Vaughan, ...
Molecular Cancer Therapeutics 16 (10), 2246-2256, 2017
302017
Four new depsides in Origanum dictamnus methanol extract
V Exarchou, PG Takis, M Malouta, J Vervoort, E Karali, AN Troganis
Phytochemistry letters 6 (1), 46-52, 2013
162013
VEGF signaling, mTOR complexes, and the endoplasmic reticulum: towards a role of metabolic sensing in the regulation of angiogenesis
E Karali, S Bellou, D Stellas, A Klinakis, C Murphy, T Fotsis
Molecular & Cellular Oncology 1 (3), e964024, 2014
152014
Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions
JR Birtley, M Alomary, E Zanini, J Antony, Z Maben, GC Weaver, ...
Nature communications 10 (1), 3134, 2019
132019
Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer
P Kreuzaler, P Inglese, A Ghanate, E Gjelaj, V Wu, Y Panina, ...
Nature Metabolism 5 (11), 1870-1886, 2023
72023
A multimodal analysis in breast cancer: Revealing metabolic heterogeneity using DESI-MS imaging with Laser-microdissection coupled transcriptome approach.
E Kazanc, E Karali, V Wu, P Inglese, J McKenzie, A Tripp, N Koundouros, ...
CANCER RESEARCH 80 (21), 2020
2020
Near Real-time Stratification of PIK3CA Mutant Breast Cancers Using the iKnife
N Koundouros, A Tripp, E Karali, A Valle, P Inglese, S Anjomani-Virmouni, ...
John Wiley & Sons, Ltd. on behalf of Pathological Society of Great Britain …, 2019
2019
Decoding The BH3-Mimetic Pro-Apoptotic Activity Of Quercetin In Jurkat Cells
A Primikyri, E Hatzimichael, E Karali, E Kostaras, M Manztaris, JS Shin, ...
Blood 122 (21), 1672, 2013
2013
FLAVONOIDS SUPPRESS TUMOUR ANGIOGENESIS BY INHIBITING VEGF SIGNALLING
S Bellou, E Bagli, E Karali, C Murphy, Fotsis
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 50, E16-E16, 2013
2013
Λειτουργικός χαρακτηρισμός γονιδίων τα οποία ρυθμίζονται από τον VEGF (Vascual Endothelial Growth Factor)
Ε Καραλή
2012
The system can't perform the operation now. Try again later.
Articles 1–17